对阿片类药物戒断程度较轻或轻微的患者使用七天丁丙诺啡是可行的

The Brown University Psychopharmacology Update Pub Date : 2024-10-01 DOI:10.1002/pu.31226

{"title":"对阿片类药物戒断程度较轻或轻微的患者使用七天丁丙诺啡是可行的","authors":"","doi":"10.1002/pu.31226","DOIUrl":null,"url":null,"abstract":"<p>Patients with opioid use disorder (OUD) who exhibited minimal to mild withdrawal at baseline experienced positive outcomes with use of an injectable 7-day formulation of buprenorphine, a nonrandomized trial has found. The study sample of 100 adults reported few serious adverse events and a high degree of satisfaction with the extended-release formulation of buprenorphine.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 11","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seven-day buprenorphine feasible in patients with minimal to mild opioid withdrawal\",\"authors\":\"\",\"doi\":\"10.1002/pu.31226\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Patients with opioid use disorder (OUD) who exhibited minimal to mild withdrawal at baseline experienced positive outcomes with use of an injectable 7-day formulation of buprenorphine, a nonrandomized trial has found. The study sample of 100 adults reported few serious adverse events and a high degree of satisfaction with the extended-release formulation of buprenorphine.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"35 11\",\"pages\":\"3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31226\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

一项非随机试验发现，阿片类药物使用障碍（OUD）患者在基线时表现出轻微至轻度戒断，但使用注射用 7 天丁丙诺啡制剂后会产生积极的效果。这项由 100 名成人组成的研究样本报告说，他们对丁丙诺啡缓释制剂的严重不良反应很少，满意度很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Seven-day buprenorphine feasible in patients with minimal to mild opioid withdrawal

Patients with opioid use disorder (OUD) who exhibited minimal to mild withdrawal at baseline experienced positive outcomes with use of an injectable 7-day formulation of buprenorphine, a nonrandomized trial has found. The study sample of 100 adults reported few serious adverse events and a high degree of satisfaction with the extended-release formulation of buprenorphine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Brown University Psychopharmacology Update

自引率

0.00%

发文量